Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders
Victoria M. Golub, Doodipala Samba Reddy
Advances in experimental medicine and biology (2020), pp. 93-110
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Cannabinoids: Therapeutic Use in Clinical Practice
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3344-3344
Open Access | Times Cited: 146
N6-methyladenosine and Neurological Diseases
Nan Zhang, Chunhong Ding, Yuxin Zuo, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1925-1937
Closed Access | Times Cited: 102
Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions
Victoria M. Golub, Doodipala Samba Reddy
Pharmacological Reviews (2022) Vol. 74, Iss. 2, pp. 387-438
Open Access | Times Cited: 58
Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
Doodipala Samba Reddy
Experimental Neurology (2022) Vol. 359, pp. 114237-114237
Open Access | Times Cited: 50
Conversion technologies for valorization of hemp lignocellulosic biomass for potential biorefinery applications
Manikant Tripathi, Minaxi Sharma, Saroj Bala, et al.
Separation and Purification Technology (2023) Vol. 320, pp. 124018-124018
Closed Access | Times Cited: 26
Inflammation and cancer: friend or foe?
Andrés David Turizo-Smith, Samantha Córdoba-Hernandez, Lidy Vannessa Mejía-Guarnizo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Drug interactions in a sample of inpatients diagnosed with cannabis use disorder
Martin Schulze Westhoff, Christina Massarou, Stefan Bleich, et al.
Journal of Neural Transmission (2025)
Open Access | Times Cited: 1
The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review
Eman A. Alraddadi, Faisal F. Aljuhani, Ghadah Y. Alsamiri, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis
Ashna Talwar, Emily R. Estes, Rajender R. Aparasu, et al.
Experimental Neurology (2022) Vol. 359, pp. 114238-114238
Open Access | Times Cited: 35
Tracing topics and trends in drug‐resistant epilepsy research using a natural language processing–based topic modeling approach
Mert Karabacak, Pemla Jagtiani, Ankita Jain, et al.
Epilepsia (2024) Vol. 65, Iss. 4, pp. 861-872
Closed Access | Times Cited: 8
Cannabinoids and Neuropsychiatric Disorders

Advances in experimental medicine and biology (2020)
Closed Access | Times Cited: 45
Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs
Dakir Polidoro, Robin Temmerman, Mathias Devreese, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 28
Cannabidiol attenuates periodontal inflammation through inhibiting TLR4/NF‐κB pathway
Hao Chen, Yaqi Liu, Sijing Yu, et al.
Journal of Periodontal Research (2023) Vol. 58, Iss. 4, pp. 697-707
Closed Access | Times Cited: 16
Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine
Soura Challal, Adrianna Skiba, Mélanie Langlois, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116740-116740
Closed Access | Times Cited: 15
Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action
Abdul Waris, Ata Ullah, Muhammad Asim, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Efficacy and safety of adjunctive antiseizure medications for dravet syndrome: A systematic review and network meta-analysis
Jian Wu, Liu Zhang, Xi Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits
Manuela Stella, Giammarco Baiardi, Stefano Pasquariello, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 582-582
Open Access | Times Cited: 11
Cannabinoid receptor 2 agonist AM1241 alleviates epileptic seizures and epilepsy-associated depression via inhibiting neuroinflammation in a pilocarpine-induced chronic epilepsy mouse model
Yiying Cai, Fangchao Tong, Kexian Li, et al.
Molecular and Cellular Neuroscience (2024) Vol. 130, pp. 103958-103958
Closed Access | Times Cited: 4
Advance in Vascular Anomalies of Head and Neck Region: From Bench to Bedside
Deming Wang
Frontiers research topics (2025)
Closed Access
Clinical Uses of Cannabinoids: What Does the Evidence Say?
Leah Sera, Carrie Hempel‐Sanderoff
(2025), pp. 43-61
Closed Access
Epidemiology and Health Impacts of Substance Use
Richard Alecsander Reichert, Flávia Zacouteguy Boos, Fernanda Machado Lopes, et al.
(2025), pp. 87-119
Closed Access
Barrier-Strengthening Effects of Cannabidiol on Porcine Peyer’s Patches
Elisa Boehm, Linda Droessler, Marie-Luise Vollstaedt, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3360-3360
Open Access
Cannabidiol Perceptions and Use in the Orthopaedic Patient Population
Bradley S. Lambert, Karen Hernandez, Haley Goble, et al.
JBJS Open Access (2025) Vol. 10, Iss. 2
Open Access
Vitiligo and Mental Health: Natural Compounds’ Usefulness
Luca Di Bartolomeo, Paolo Custurone, Natasha Irrera, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 176-176
Open Access | Times Cited: 10
Investigation of neuroprotective and therapeutic effects of cannabidiol in an acute coronary syndrome model
Melike Doğan Ünlü, Derya Uysal, Nasıf Fatih Karakuyu, et al.
Neuroscience Letters (2024) Vol. 825, pp. 137689-137689
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top